Skip header and navigation

2 records – page 1 of 1.

Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: data from 35 955 24-hour dietary recalls in 10 European countries.

https://arctichealth.org/en/permalink/ahliterature18551
Source
Public Health Nutr. 2002 Dec;5(6B):1259-71
Publication Type
Article
Date
Dec-2002
Author
A. Hjartåker
A. Lagiou
N. Slimani
E. Lund
M D Chirlaque
E. Vasilopoulou
X. Zavitsanos
F. Berrino
C. Sacerdote
M C Ocké
P H M Peeters
D. Engeset
G. Skeie
A. Aller
P. Amiano
G. Berglund
S. Nilsson
A. McTaggart
E A Spencer
K. Overvad
A. Tjønneland
F. Clavel-Chapelon
J. Linseisen
M. Schulz
B. Hemon
E. Riboli
Author Affiliation
Section of Medical Statistics, University of Oslo, PO Box 1122, Blindern, N-0317 Norway. anette.hjartaker@basalmed.uio.no
Source
Public Health Nutr. 2002 Dec;5(6B):1259-71
Date
Dec-2002
Language
English
Publication Type
Article
Keywords
Adult
Aged
Dairy Products
Diet
Diet Surveys
Europe
Female
Humans
Male
Mental Recall
Middle Aged
Population Surveillance - methods
Prospective Studies
Research Support, Non-U.S. Gov't
Abstract
OBJECTIVES: To describe and compare the consumption of dairy products in cohorts included in the European Prospective Investigation into Cancer and Nutrition (EPIC). METHODS: Data from single 24-hour dietary recall interviews collected through a highly standardised computer-based program (EPIC-SOFT) in 27 redefined centres in 10 European countries between 1995 and 2000. From a total random sample of 36 900, 22 924 women and 13 031 men were selected after exclusion of subjects under 35 and over 74 years of age. RESULTS: A high total consumption of dairy products was reported in most of the centres in Spain and in the UK cohort sampled from the general population, as well as in the Dutch, Swedish and Danish centres. A somewhat low consumption was reported in the Greek centre and in some of the Italian centres (Ragusa and Turin). In all centres and for both sexes, milk constituted the dairy sub-group with the largest proportion (in grams) of total dairy consumption, followed by yoghurt and other fermented milk products, and cheese. Still, there was a wide range in the contributions of the different dairy sub-groups between centres. The Spanish and Nordic centres generally reported a high consumption of milk, the Swedish and Dutch centres reported a high consumption of yoghurt and other fermented milk products, whereas the highest consumption of cheese was reported in the French centres. CONCLUSION: The results demonstrate both quantitative and qualitative disparities in dairy product consumption among the EPIC centres. This offers a sound starting point for analyses of associations between dairy intake and chronic diseases such as cancer.
PubMed ID
12639231 View in PubMed
Less detail

Standardization of the 24-hour diet recall calibration method used in the european prospective investigation into cancer and nutrition (EPIC): general concepts and preliminary results.

https://arctichealth.org/en/permalink/ahliterature20649
Source
Eur J Clin Nutr. 2000 Dec;54(12):900-17
Publication Type
Article
Date
Dec-2000
Author
N. Slimani
P. Ferrari
M. Ocké
A. Welch
H. Boeing
M. Liere
V. Pala
P. Amiano
A. Lagiou
I. Mattisson
C. Stripp
D. Engeset
R. Charrondière
M. Buzzard
W. Staveren
E. Riboli
Author Affiliation
Unit of Nutrition and Cancer, International Agency for Research on Cancer, Lyon, France. Slimani@iarc.fr
Source
Eur J Clin Nutr. 2000 Dec;54(12):900-17
Date
Dec-2000
Language
English
Publication Type
Article
Keywords
Analysis of Variance
Calibration
Diet Records
Diet Surveys
Female
Humans
Interviews
Male
Models, Statistical
Prejudice
Reference Standards
Abstract
OBJECTIVES: Despite increasing interest in the concept of calibration in dietary surveys, there is still little experience in the use and standardization of a common reference dietary method, especially in international studies. In this paper, we present the general theoretical framework and the approaches developed to standardize the computer-assisted 24 h diet recall method (EPIC-SOFT) used to collect about 37 000 24-h dietary recall measurements (24-HDR) from the 10 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). In addition, an analysis of variance was performed to examine the level of standardization of EPIC-SOFT across the 90 interviewers involved in the study. METHODS: The analysis of variance used a random effects model in which mean energy intake per interviewer was used as the dependent variable, while age, body mass index (BMI), energy requirement, week day, season, special diet, special day, physical activity and the EPIC-SOFT version were used as independent variables. The analysis was performed separately for men and women. RESULTS: The results show no statistical difference between interviewers in all countries for men and five out of eight countries for women, after adjustment for physical activity and the EPIC-SOFT program version used, and the exclusion of one interviewer in Germany (for men), and one in Denmark (for women). These results showed an interviewer effect in certain countries and a significant difference between gender, suggesting an underlying respondent's effect due to the higher under-reporting among women that was consistently observed in EPIC. However, the actual difference between interviewer and country mean energy intakes is about 10%. Furthermore, no statistical differences in mean energy intakes were observed across centres from the same country, except in Italy and Germany for men, and France and Spain for women, where the populations were recruited from areas scattered throughout the countries. CONCLUSION: Despite these encouraging results and the efforts to standardize the 24-HDR interview method, conscious or unconscious behaviour of respondents and/or interviewer bias cannot be prevented entirely. Further evaluation of the reliability of EPIC-SOFT measurements will be conducted through validation against independent biological markers (nitrogen, potassium).
PubMed ID
11114689 View in PubMed
Less detail